Search Results - Puisieux, A
- Showing 1 - 12 results of 12
-
1
A twist for survival and cancer progression by Puisieux, A, Valsesia-Wittmann, S, Ansieau, S
Published 2006Text -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics by Galmarini, C M, Kamath, K, Vanier-Viornery, A, Hervieu, V, Peiller, E, Falette, N, Puisieux, A, Ann Jordan, M, Dumontet, C
Published 2003Text -
10
Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity by Galmarini, C M, Falette, N, Tabone, E, Levrat, C, Britten, R, Voorzanger-Rousselot, N, Roesch-Gateau, O, Vanier-Viornery, A, Puisieux, A, Dumontet, C
Published 2001Text -
11
Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype by Grelier, G, Voirin, N, Ay, A-S, Cox, D G, Chabaud, S, Treilleux, I, Léon-Goddard, S, Rimokh, R, Mikaelian, I, Venoux, C, Puisieux, A, Lasset, C, Moyret-Lalle, C
Published 2009Text -
12
Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells by Kogan-Sakin, I, Tabach, Y, Buganim, Y, Molchadsky, A, Solomon, H, Madar, S, Kamer, I, Stambolsky, P, Shelly, A, Goldfinger, N, Valsesia-Wittmann, S, Puisieux, A, Zundelevich, A, Gal-Yam, E N, Avivi, C, Barshack, I, Brait, M, Sidransky, D, Domany, E, Rotter, V
Published 2011Text